Recruiting NA Low Back Pain

New treatment option for Low Back Pain

Official title Proprioceptive, Fear-related and Inflammatory Factors in the Persistence of Pregnancy-related Lumbopelvic Pain.

ClinicalTrials.gov ID: NCT06785909

What this study is testing

What it's testing
Pregnancy-related lumbopelvic pain (PLPP) affects 50-90% of pregnant women and is often dismissed as a normal part of pregnancy. However, the long-term consequences can be dramatic.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 40, women only

You may be able to join if

  • Informed consent to participate
  • 18-40 years old
  • Pregnant
  • Singleton pregnancy (confirmed through ultrasound)
  • No current PLPP

You likely can't join if

  • Pregnant for more than 16 weeks
  • Currently experiencing PLPP, or having had PLPP during the index pregnancy
  • History of surgery or major trauma to the spine or pelvis, major trauma or surgery to the lower limbs more than 2 years ago with current residual...
  • Specific vestibular or balance disorders
  • Use of medication that could affect balance (e.g., ototoxic or centrally-acting drugs)
  • Having a medical diagnosis for, being treated by a rheumatologist for, or taking medication for a rheumatic condition
See the full eligibility criteria
Who can join
  • Informed consent to participate
  • 18-40 years old
  • Pregnant
  • Singleton pregnancy (confirmed through ultrasound)
  • No current PLPP
  • Dutch- or English-speaking
What rules you out
  • Pregnant for more than 16 weeks
  • Currently experiencing PLPP, or having had PLPP during the index pregnancy
  • History of surgery or major trauma to the spine or pelvis, major trauma or surgery to the lower limbs more than 2 years ago with current residual symptoms (e.g., pain, instability, stiffness), major trauma or surgery to...
  • Specific vestibular or balance disorders
  • Use of medication that could affect balance (e.g., ototoxic or centrally-acting drugs)
  • Having a medical diagnosis for, being treated by a rheumatologist for, or taking medication for a rheumatic condition
  • (History of) a neurological disorder (e.g., neuropathy)
  • Problems with vision that are not corrected by glasses, contact lenses or surgical eye correction
  • Recent history of ankle problem (e.g., ankle sprain less than 3 weeks ago)
  • Being on absolute/relative bed rest due to pregnancy complications
  • (History of) inflammatory (e.g., gout, endometriosis), (auto)immune (e.g., lupus, ankylosis spondylitis, rheumatoid arthritis, psoriasis, Crohn's disease, Graves' disease, Hashimoto's thyroiditis, colitis ulcerosa...
  • Having (had) a formal diagnosis of a psychiatric disorder (e.g., psychotic disorder).

The study team makes the final eligibility decision.

Where it's taking place

  • Hasselt, Belgium
  • Leuven, Belgium

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 40 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Hasselt, Belgium; Leuven, Belgium. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.